People with type 1 diabetes who depend on human insulin made by Novo Nordisk will instead be given glass vials and syringes - said to be inconvenient and harder to use with the same precision. Novo Nordisk has already stopped supply in South Africa, where patients have had to switch to glass vials. Novo Nordisk's decision is linked to its favoring of the marketing of the slimming drugs Ozempic and Wegovy.
Sources
O companie farmaceutică ar fi oprit producţia de seringi cu insulină pentru a vinde produse de slăbit
Weight-loss drug firm accused of prioritising profits after halting insulin pen production
Novo Nordisk, compania producătoare de medicamente folosite pentru pierderea în greutate, acuzată că prioritizează profiturile după oprirea producției de stilouri cu insulină
Latest News
18:40
UE ajunge la un acord pentru amânarea cu doi ani a obligațiilor privind metanul din importurile de gaze, petrol și cărbune
18:38
Health Minister Alexandru Rogobete discusses new measures for hospitals and medicine stocks with NATO
18:31
The Chamber of Tax Consultants warns: ANAF’s new rules for VAT refunds could block investments
18:19
Eurostat shows employment gaps of at least 18 percentage points between men and women in five regions of Romania
18:19
Two ANAF employees from Argeș were detained after allegedly asking for 40,000 lei to conceal tax irregularities
See more news